Hepatocyte Growth Factor and Cardiovascular Autonomic Function

This study has been completed.
Sponsor:
Information provided by:
Oita Red Cross Hospital
ClinicalTrials.gov Identifier:
NCT00478127
First received: May 23, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.


Condition
Type-2 Diabetes

Study Type: Observational
Study Design: Allocation: Random Sample
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Oita Red Cross Hospital:

  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Type-2 diabetes

Exclusion Criteria:

  • Type-1 diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00478127

Sponsors and Collaborators
Oita Red Cross Hospital
Investigators
Principal Investigator: Futoshi Anan Oita Red Cross Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00478127     History of Changes
Other Study ID Numbers: AO-272
Study First Received: May 23, 2007
Last Updated: May 23, 2007
Health Authority: Japan: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 20, 2014